Safety and Efficacy Study of MBX-102 in Treatment of Hyperuricemia in Patients With Gout

NCT01336686 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

67

Enrollment

INDUSTRY

Sponsor class

Conditions

Hyperuricemia
Gout

Interventions

DRUG: Arhalofenate
DRUG: Arhalofenate
DRUG: Placebo comparator
DRUG: Colchicine

Sponsor

Gilead Sciences